Unlock instant, AI-driven research and patent intelligence for your innovation.

Curcumin-peptide conjugates and formulations

a technology of curcumin and peptides, which is applied in the field of nutraceutical formulations, can solve the problems of curcumin's poor solubility, limited in vivo suitability for in vivo studies, and curcumin's poor solubility, and reduces the bioavailability of curcumin throughout the body

Inactive Publication Date: 2016-12-22
CHANCEY JOHN ROBERT
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

Significantly increases serum bioavailability of curcumin, allowing for effective therapeutic concentrations and symptom relief in disorders like arthritis, inflammatory bowel disease, and neurodegenerative diseases, with minimal side effects and improved solubility in water.

Problems solved by technology

Medicinal use of curcumin has been limited because the compound is virtually insoluble (dissolution of only ca.
Those solvents include dimethylsulfoxide (DMSO), acetone and ethanol but they have limited suitability for in vivo studies themselves.
Curcumin's poor solubility decreases its bioavailability throughout the body, and specifically at the brain, where curcumin does not readily cross the brain-blood barrier.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Curcumin-peptide conjugates and formulations

Examples

Experimental program
Comparison scheme
Effect test

example 1

Preparation of Curcumin-Whey Protein Isolate Complex

[0047]A curcumin-WPI complex was prepared for administration to human subjects. The following materials were used:

WPI:85% protein by weightCurcumin powder:95% curcuminoidsEthanol:100% ethyl alcohol

[0048]Ratio of curcumin:WPI of 1:50 w / w. A 0.5% w / v tincture (solution) was prepared by mixing 5 g curcumin powder with 1000 mL ethanol. The mixture was placed on a magnetic stirring hot plate, with a speed setting at medium, and temperature setting at 50° C. for 30 minutes or until solution turned clear. To the resulting solution was added 250 g WPI powder. The mixture was placed on a rotary evaporator (rotovap) at slow speed (20-30 rpm), having a water bath temperature of 50° C., and low vacuum for 30 minutes, or until 90% of the ethanol was evaporated. The resulting mixture was placed in a kiln oven to remove the remainder of the ethanol. Alternatively, the mixture was placed in a lyophilizer, or alternatively, was placed in a flow hoo...

example 2

Preparation of Curcumin-Amino Acid Complexes

[0052]Following the method of Example 1, curcumin was dissolved in 95% ethanol, followed by the addition of N-acetyl cysteine (NAC). An escalating ratio of the concentrations of curcumin to n-acetyl cysteine was used to find the saturation level. The optimal concentration was found at around 100 mg of curcumin to 1000 mg of NAC in a 0.5% (w / v) solution of curcumin in ethanol. Optimal concentration was noted when low number of Curcumin crystal formation was observed in the macroscopic field.

[0053]Similarly, curcumin was dissolved in 95% ethanol, followed by the addition of cysteine. An escalating ratio of the concentrations of curcumin to cysteine was used to find the saturation level. The optimal concentration was found at around 100 mg of curcumin to 1000 mg of cysteine in a 0.5% (w / v) solution of curcumin in ethanol. Optimal concentration was noted when low number of Curcumin crystal formation was observed in the macroscopic field.

[0054]...

example 3

Administration of Curcumin:WPI Complex

[0056]Two healthy individuals were administered a single dose of the curcumin:WPI complex, having a ratio of curcumin:WPI of 25:1 w / w (mg:g). The dosage contained 25 mg of curcumin. Blood was drawn from each individual at 20 min, 50 min, and 90 min, and the level of serum curcumin was calculated. The results are shown in Table 1, below.

TABLE 1Subject ATime (min)205090Avg (ng / mL)1426.81162.0212.7StDev1200.0932.551.1Subject BTime (min)305090Avg (ng / mL)2716.62011.2508.4StDevN / A997.6284.6

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
temperatureaaaaaaaaaa
concentrationaaaaaaaaaa
concentrationaaaaaaaaaa
Login to View More

Abstract

Disclosed here are compositions comprising a curcuminoid-peptide complex. Also disclosed are therapeutic compositions comprising a curcuminoid-peptide complex as described and a pharmaceutically acceptable excipient, diluent, or carrier.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application claims priority to U.S. Provisional Application Ser. No. 61 / 992,123 filed May 12, 2014, and U.S. application Ser. No. 14 / 710,578 filed May 12, 2015, the entire contents of each are incorporated herein by reference.TECHNICAL FIELD OF THE INVENTION[0002]The present invention is in the field of formulations of nutraceuticals, and more specifically, in the field of formulations having bioavailable curcuminoids.STATEMENT OF FEDERALLY FUNDED RESEARCH[0003]None.INCORPORATION-BY-REFERENCE OF MATERIALS FILED ON COMPACT DISC[0004]None.BACKGROUND OF THE INVENTION[0005]Turmeric is a curry spice obtained from the rhizome of Curcuma longa of the ginger family, and has a long history of use in ayurvedic medicine and in traditional Asian diets. The principal bioactive component of turmeric is curcumin (1,7-bis[4-hydroxy-3-methoxyphenyl]-1,6-heptadiene-3,5-dione), a yellow pigment first identified in 1910. Curcumin is used widely in the U...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K47/48A61K31/12C07K14/47
CPCA61K47/48238A61K31/12C07K14/47C07K14/76C07K14/4717A61K47/542A61K47/64A61P1/04A61P11/06A61P17/06A61P19/02A61P25/00A61P25/16A61P25/28A61P27/12A61P29/00A61P31/12A61P31/18A61P33/06A61P3/06A61P37/06A61P37/08A61P43/00A61P9/10A61P3/10Y02A50/30A61K38/17A61K38/38A61P37/00
Inventor CHANCEY, JOHN ROBERT
Owner CHANCEY JOHN ROBERT